In a first, researchers have developed a portable 3D skin printer that deposits even layers of tissue to cover and heal deep wounds within minutes. For patients with deep skin wounds, all three skin layers – the epidermis, dermis and hypodermis – may be heavily damaged.
The current preferred treatment is called split-thickness skin grafting, where healthy donor skin is grafted onto the surface epidermis and part of the underlying dermis. Split-thickness grafting on large wounds requires enough healthy donor skin to traverse all three layers, and sufficient graft skin is rarely available. This leaves a portion of the wounded area “ungrafted” or uncovered, leading to poor healing outcomes.
Although a large number of tissue-engineered skin substitutes exist, they are not yet widely used in clinical settings. “Most current 3D bioprinters are bulky, work at low speeds, are expensive and are incompatible with clinical application,” said Axel Guenther from the University of Toronto in Canada. The team believes their in-situ skin printer is a platform technology that can overcome these barriers, while improving the skin-healing process – a major step forward.
The handheld skin printer resembles a white-out tape dispenser – except the tape roll is replaced by a microdevice that forms tissue sheets. Vertical stripes of “bio-ink,” made up of protein-based biomaterials including collagen, the most abundant protein in the dermis, and fibrin, a protein involved in wound healing, run along the inside of each tissue sheet. “Our skin printer promises to tailor tissues to specific patients and wound characteristics. And it’s very portable,” said Navid Hakimi, PhD student at the University of Toronto.
The handheld device is the size of a small shoebox and weighs less than a kilogramme. It also requires minimal operator training and eliminates the washing and incubation stages required by many conventional bioprinters. The researchers plan to add several capabilities to the printer, including expanding the size of the coverable wound areas. Working with Jeschke’s team at Sunnybrook Hospital, they plan to perform more in vivo studies. They hope that one day they can begin running clinical trials on humans, and eventually revolutionise burn care.